PUBLICATION
SMC Laboratories is highly regarded worldwide as a consulting CRO that designs studies in line with the demands of pharmaceutical companies and research institutions.
In particular, in the NASH-HCC field, SMC is a highly regarded CRO, because of our unique STAM™ mice.
The results achieved with our STAM™ have been introduced in academic publications as well as scientific conferences.
Publications
2000 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
No.65
Transl Oncol Clin Exp Hepatol.,
“Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments” (Transl Oncol., DOI: 10.1016/j.tranon.2021.101201., 2021)
VIEW ARTICLE 
No.64
Surgery Open Science.,
“In vivo diffuse reflectance spectroscopic analysis of fatty liver with I inflammation in mice” (Surg Open Sci., DOI: 10.1016/j.sopen.2021.07.002., 2021)
VIEW ARTICLE